Xu B[Author] - Search Results

Year	Number of Results
1979	3
1980	7
1981	13
1982	4
1983	8
1984	5
1985	11
1986	10
1987	13
1988	11
1989	13
1990	10
1991	15
1992	16
1993	22
1994	44
1995	34
1996	33
1997	33
1998	43
1999	53
2000	53
2001	56
2002	86
2003	122
2004	133
2005	157
2006	178
2007	184
2008	287
2009	272
2010	359
2011	461
2012	537
2013	651
2014	855
2015	881
2016	920
2017	1131
2018	1204
2019	1370
2020	1597
2021	1804
2022	2034
2023	1949
2024	2156
2025	1270

1

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer.

Zhang Y, Chen H, Mo H, Zhao N, Sun X, Liu B, Gao R, Xu B, Zhang Z, Liu Z, Ma F. Zhang Y, et al. Among authors: xu b. Cancer Cell. 2025 Mar 10;43(3):446-463.e7. doi: 10.1016/j.ccell.2025.01.007. Epub 2025 Feb 6. Cancer Cell. 2025. PMID: 39919737 Free article.

2

Non-Risk-Based Lung Cancer Screening With Low-Dose Computed Tomography.

Li C, Cheng B, Li J, Xiong S, Fu W, Jiang Y, Zhou C, Zhong R, Li F, Zhang Q, Liang H, Wang W, Yang CJ, Potter AL, Du X, Qiu Q, Yang C, Sun B, Chen Y, Liu J, Xu B, Zhong N, Liang W, He J; LUNG-CARE Project. Li C, et al. Among authors: xu b. JAMA. 2025 Jun 17;333(23):2108-2110. doi: 10.1001/jama.2025.4017. JAMA. 2025. PMID: 40257816

3

An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.

Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y, Caligiuri MA, Yu J. Ma R, et al. Among authors: xu b. Cancer Res. 2021 Jul 1;81(13):3635-3648. doi: 10.1158/0008-5472.CAN-21-0035. Epub 2021 May 18. Cancer Res. 2021. PMID: 34006525 Free PMC article.

4

Metal-centred planar [15]annulenes.

Xu B, Chen D, Ruan K, Luo M, Cai Y, Qiu J, Zhou W, Cao B, Lin Z, Sessler JL, Xia H. Xu B, et al. Nature. 2025 May;641(8061):106-111. doi: 10.1038/s41586-025-08841-2. Epub 2025 Apr 30. Nature. 2025. PMID: 40307519

5

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway.

Zhan M, Xu H, Yu G, Chen Q, Yang R, Chen Y, Ge J, Wang Z, Yang R, Xu B. Zhan M, et al. Among authors: xu b. Redox Biol. 2024 Sep;75:103298. doi: 10.1016/j.redox.2024.103298. Epub 2024 Aug 2. Redox Biol. 2024. PMID: 39121689 Free PMC article.

6

HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial.

Li Q, Cheng Y, Tong Z, Liu Y, Wang X, Yan M, Chang J, Wang S, Du C, Li L, Wu C, Wang M, Wang Z, Wu Z, Wang X, Jin Y, Diao L, Sun Y, Zhang Y, Hui AM, Xu B. Li Q, et al. Among authors: xu b. Nat Commun. 2024 Jun 17;15(1):5158. doi: 10.1038/s41467-024-48798-w. Nat Commun. 2024. PMID: 38886347 Free PMC article. Clinical Trial.

7

A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial.

Xu B, Geerts D, Yuan J, Wang M, Li Z, Lai Q, Zheng Y, Liu S, Yang S, Zhu G, Jin L. Xu B, et al. Hum Reprod. 2024 Sep 1;39(9):1969-1978. doi: 10.1093/humrep/deae145. Hum Reprod. 2024. PMID: 38942602 Clinical Trial.

8

NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers.

Zhu X, Li Y, Liu H, Wang Y, Sun R, Jiang Z, Hou C, Hou X, Huang S, Zhang H, Wang H, Jiang B, Yang X, Xu B, Fan G. Zhu X, et al. Among authors: xu b. Cell Chem Biol. 2024 Jun 20;31(6):1203-1218.e17. doi: 10.1016/j.chembiol.2024.05.007. Cell Chem Biol. 2024. PMID: 38906111

9

Seeding activity of skin misfolded tau as a biomarker for tauopathies.

Wang Z, Wu L, Gerasimenko M, Gilliland T, Shah ZSA, Lomax E, Yang Y, Gunzler SA, Donadio V, Liguori R, Xu B, Zou WQ. Wang Z, et al. Among authors: xu b. Mol Neurodegener. 2024 Nov 29;19(1):92. doi: 10.1186/s13024-024-00781-1. Mol Neurodegener. 2024. PMID: 39609917 Free PMC article.

10

Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

Shao Z, Tong Z, Liu Q, Li W, Cai L, Shen K, Li H, Wang C, Yang J, Song Z, Wang S, Luo T, Zhao W, Wang H, Pan Y, Nie J, Zeng X, Bai Y, Chiang W, Guarnaccia V, Bi Y, Xu B. Shao Z, et al. Among authors: xu b. Cancer Med. 2024 Aug;13(15):e7408. doi: 10.1002/cam4.7408. Cancer Med. 2024. PMID: 39136200 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,899 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,899 results

Results by year